Heron Therapeutics Inc vs Shopify Inc. — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Shopify Inc. trades at $152 (market cap $196.35B). The key difference: Shopify Inc. is far larger — about 3194.2× Heron Therapeutics Inc's market cap, and Shopify Inc. is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | SHOP | |
|---|---|---|
Market Cap | $61.47M | $196.35B |
Sector | Health | Technology |
52-Week High | $1.49 | $179.01 |
52-Week Low | $0.32 | $95.40 |
Enterprise Value | $168.21M | $191.59B |
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) trades at $0.49, down 1.64% today, with a bearish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed earnings expectations with a $0.03 loss per share. Despite negative net income margins, HRTX maintains strong analyst support with 94.7% buy ratings. Recent news highlights patent litigation developments and quarterly earnings underperformance.
HRTX faces significant fundamental challenges with persistent losses and declining revenue projections, though analyst consensus remains overwhelmingly bullish. Investment opportunity exists if the company can achieve profitability and meet growth targets, but risks include ongoing operational losses, competitive pressures, and execution challenges in the biotechnology sector.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →